Esperion Therapeutics (ESPR) Inventory Average: 2020-2025
Historic Inventory Average for Esperion Therapeutics (ESPR) over the last 6 years, with Sep 2025 value amounting to $111.5 million.
- Esperion Therapeutics' Inventory Average rose 35.51% to $111.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.5 million, marking a year-over-year increase of 35.51%. This contributed to the annual value of $80.1 million for FY2024, which is 58.81% up from last year.
- Per Esperion Therapeutics' latest filing, its Inventory Average stood at $111.5 million for Q3 2025, which was up 4.31% from $106.9 million recorded in Q2 2025.
- In the past 5 years, Esperion Therapeutics' Inventory Average registered a high of $111.5 million during Q3 2025, and its lowest value of $18.1 million during Q1 2021.
- Over the past 3 years, Esperion Therapeutics' median Inventory Average value was $78.8 million (recorded in 2024), while the average stood at $74.5 million.
- As far as peak fluctuations go, Esperion Therapeutics' Inventory Average skyrocketed by 333.58% in 2021, and later fell by 5.30% in 2022.
- Over the past 5 years, Esperion Therapeutics' Inventory Average (Quarterly) stood at $34.2 million in 2021, then fell by 5.30% to $32.4 million in 2022, then skyrocketed by 80.80% to $58.5 million in 2023, then spiked by 49.15% to $87.3 million in 2024, then soared by 35.51% to $111.5 million in 2025.
- Its Inventory Average stands at $111.5 million for Q3 2025, versus $106.9 million for Q2 2025 and $96.9 million for Q1 2025.